These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22957374)

  • 21. Structure and Development of the List of Prohibited Substances and Methods.
    Kinahan A; Budgett R; Mazzoni I
    Med Sport Sci; 2017; 62():39-54. PubMed ID: 28571027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
    Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
    Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood doping at the Olympic Games.
    Fitch KD
    J Sports Med Phys Fitness; 2017 Nov; 57(11):1526-1532. PubMed ID: 28094487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-doping analyses at the Sochi Olympic and Paralympic Games 2014.
    Sobolevsky T; Krotov G; Dikunets M; Nikitina M; Mochalova E; Rodchenkov G
    Drug Test Anal; 2014; 6(11-12):1087-101. PubMed ID: 25312500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proceedings of the 28th Manfred Donike Cologne Workshop on Dope Analysis. March 2010. Cologne, Germany.
    Drug Test Anal; 2010; 2(11-12):523-650. PubMed ID: 21534260
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification of Factors Associated with Potential Doping Behavior in Sports: A Cross-Sectional Analysis in High-Level Competitive Swimmers.
    Devcic S; Bednarik J; Maric D; Versic S; Sekulic D; Kutlesa Z; Bianco A; Rodek J; Liposek S
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30103461
    [No Abstract]   [Full Text] [Related]  

  • 27. Point: the quest for clean competition in sports: are we the dopes?
    Baird GS
    Clin Chem; 2014 Oct; 60(10):1276-8. PubMed ID: 25059629
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug misuse in sport: a New Zealand perspective.
    Curtis A; Gerrard D; Burt P; Osborne H
    N Z Med J; 2015 Dec; 128(1426):62-8. PubMed ID: 26913908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The sports psychiatrist and performance-enhancing drugs.
    Creado S; Reardon C
    Int Rev Psychiatry; 2016 Dec; 28(6):564-571. PubMed ID: 27310472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What every physician should know about doping and doping control.
    Lazzoli JK
    Rev Assoc Med Bras (1992); 2016 Apr; 62(2):101-5. PubMed ID: 27167536
    [No Abstract]   [Full Text] [Related]  

  • 31. [Doping affects the entire society].
    Sundberg CJ
    Lakartidningen; 2013 Sep 25-Oct 8; 110(39-40):1727. PubMed ID: 24245426
    [No Abstract]   [Full Text] [Related]  

  • 32. Counterpoint: the quest for clean competition in sports: deterrence and the role of detection.
    Bowers LD
    Clin Chem; 2014 Oct; 60(10):1279-81. PubMed ID: 25059630
    [No Abstract]   [Full Text] [Related]  

  • 33. Prediction profiles for nutritional supplement use among young German elite athletes.
    Dietz P; Ulrich R; Niess A; Best R; Simon P; Striegel H
    Int J Sport Nutr Exerc Metab; 2014 Dec; 24(6):623-31. PubMed ID: 24901677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use and misuse of hormones in sport.
    Sonksen PH; Cowan D; Holt RI
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):882-883. PubMed ID: 27542991
    [No Abstract]   [Full Text] [Related]  

  • 35. Gender difference in platelet aggregation and reactivity induced by recombinant human erythropoietin.
    Gambardella L; Vona R; Pichini S; Pacifici R; Malorni W; Straface E
    Br J Clin Pharmacol; 2016 Apr; 81(4):789-91. PubMed ID: 26592206
    [No Abstract]   [Full Text] [Related]  

  • 36. The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes.
    Striegel H; Rössner D; Simon P; Niess AM
    Int J Sports Med; 2005 Apr; 26(3):238-43. PubMed ID: 15776342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Judgments about illegal performance-enhancing substances: reasoned, reactive, or both?
    Dodge T; Stock M; Litt D
    J Health Psychol; 2013 Jul; 18(7):962-71. PubMed ID: 23027783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analgesics use in competitive triathletes: its relationship to doping and on predicting its usage.
    Dietz P; Dalaker R; Letzel S; Ulrich R; Simon P
    J Sports Sci; 2016 Oct; 34(20):1965-9. PubMed ID: 26911564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sports, medicine and doping].
    Ersson B
    Lakartidningen; 2016 Dec; 113():. PubMed ID: 27922713
    [No Abstract]   [Full Text] [Related]  

  • 40. Annual banned-substance review: Analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2019 Jan; 11(1):8-26. PubMed ID: 30488582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.